Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:15 PM View:  | Bioatla, Inc. (BCAB) | 13-Jun-24 | Grant | 16,500 | -- | -- | 43% 38.46K to 54.96K | |
| 19-Dec-23 8:24 PM View: | Bioatla, Inc. (BCAB) | 19-Dec-23 | Private Purchase | 20,000 | $2.05 | $41,048.00 | 108% 18.46K to 38.46K | |
| 06-Jun-23 10:00 PM View: | Pasithea Therapeutics Corp. (KTTA) | 02-Jun-23 | Private Purchase | 30,000 | $0.43 | $12,930.00 | 2% 1.3M to 1.33M | |
| 02-Jun-23 8:00 AM View: | 180 Life Sciences Corp. (ATNF) | 01-Jun-23 | Private Purchase | 18,000 | $1.23 | $22,068.00 | 60% 30.13K to 48.13K | |
| 28-Nov-22 4:00 PM View: | Pasithea Therapeutics Corp. (KTTA) | 28-Nov-22 | Grant | 5,000 | $0.98 | $4,900.00 | < 1% 1.28M to 1.29M | |
| 22-Nov-22 4:10 PM View: | Pasithea Therapeutics Corp. (KTTA) | 22-Nov-22 | Grant | 5,000 | $0.99 | $4,950.00 | < 1% 1.28M to 1.28M | |
| 26-Oct-22 5:35 PM View: | Pasithea Therapeutics Corp. (KTTA) | 26-Oct-22 | Grant | 5,000 | $1.10 | $5,500.00 | < 1% 1.27M to 1.28M | |
| 17-Oct-22 6:11 PM View: | Pasithea Therapeutics Corp. (KTTA) | 17-Oct-22 | Grant | 10,000 | $1.13 | $11,310.00 | < 1% 1.26M to 1.27M | |
| 30-Jun-22 4:15 PM View: | Pasithea Therapeutics Corp. (KTTA) | 29-Jun-22 | Grant | 5,000 | $1.00 | $5,000.00 | < 1% 1.27M to 1.27M | |
| 30-Jun-22 4:15 PM View: | Pasithea Therapeutics Corp. (KTTA) | 28-Jun-22 | Grant | 5,000 | $1.02 | $5,100.00 | < 1% 1.26M to 1.27M | |
| 27-Jun-22 4:15 PM View: | Pasithea Therapeutics Corp. (KTTA) | 27-Jun-22 | Grant | 5,000 | $1.00 | $5,000.00 | < 1% 1.26M to 1.26M | |
| 23-Jun-22 4:31 PM View: | Pasithea Therapeutics Corp. (KTTA) | 23-Jun-22 | Grant | 5,000 | $1.00 | $5,000.00 | < 1% 1.25M to 1.26M | |
| 22-Jun-22 4:30 PM View: | Pasithea Therapeutics Corp. (KTTA) | 21-Jun-22 | Grant | 652,174 | -- | -- | 109% 600.0K to 1.25M | |
| 10-Dec-21 8:22 AM View: | 180 Life Sciences Corp. (ATNF) | 09-Dec-21 | Market Purchase | 5,000 | $4.27 | $21,350.00 | < 1% 597.57K to 602.57K | (6%) |
| 03-Nov-21 5:09 PM View: | Bioatla, Inc. (BCAB) | 02-Nov-21 | Market Sale (Planned) | 450 | $30.00 | $13,500.00 | (2%) 18.91K to 18.46K | < 1% |
| 05-Oct-21 8:16 AM View: | 180 Life Sciences Corp. (ATNF) | 30-Sep-21 | Grant | 5,216 | $6.00 | $31,296.00 | < 1% 592.36K to 597.57K | (10%) |
| 17-Sep-21 2:05 PM View: | Bioatla, Inc. (BCAB) | 15-Sep-21 | Market Sale (Planned) | 450 | $36.82 | $16,569.00 | (2%) 19.36K to 18.91K | < 1% |
| 18-Aug-21 5:48 PM View: | Bioatla, Inc. (BCAB) | 16-Aug-21 | Market Sale (Planned) | 450 | $40.60 | $18,270.00 | (2%) 19.81K to 19.36K | (3%) |
| 19-Jul-21 9:25 PM View: | Bioatla, Inc. (BCAB) | 15-Jul-21 | Market Sale (Planned) | 450 | $38.29 | $17,230.50 | (2%) 20.26K to 19.81K | (2%) |
| 16-Jun-21 9:27 PM View: | Bioatla, Inc. (BCAB) | 14-Jun-21 | Acquisition (other) | 5,388 | -- | -- | 36% 14.87K to 20.26K | |
| 08-Apr-21 8:00 AM View: | 180 Life Sciences Corp. (ATNF) | 07-Apr-21 | Grant | 22,585 | $6.14 | $138,672.00 | 4% 569.77K to 592.36K | 7% |
| 24-Jun-19 4:51 PM View: | Atreca, Inc. (BCEL) | 24-Jun-19 | Conversion | 8,405 | -- | -- | 3% 250.0K to 258.4K | |
| 02-Mar-05 2:24 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Mar-05 | Market Sale | 4,000 | $41.10 | $164,406.00 | (21%) 19.5K to 15.5K | (182%) |
| 17-Sep-04 10:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-Sep-04 | Market Sale | 2,000 | $50.25 | $100,509.00 | (9%) 21.5K to 19.5K | (130%) |